The KROG 12-05 [35] study is a retrospective trial that evaluated the role of loco-regional RT in patients undergoing mastectomy vs non-loco-regional RT on a sample of 151 breast cancer patients with cN2 at diagnosis. The gene discussed is CNDP2; the disease is breast carcinoma.